Abstract
Identifying drug candidates to target cellular events/signaling that evades von Hippel-Lindau tumor suppressor (VHL) gene interaction is critical for the cure of renal cell carcinoma (RCC). Recently, we characterized a triterpene-squalene derived from marine brown alga. Herein, we investigated the potential of squalene in targeting HIF-signaling and other drivers of RCC progression. Squalene inhibited cell proliferation, induced cell dealth and reverted the cells' metastatic state (migration, clonal expansion) independent of their VHL status. Near-identical inhibition of HIF-1α and HIF-2α and the regulation of downstream targets in VHL wild type and mutant cell lines demonstrated squalene efficacy beyond VHL-HIF interaction. In a rat model of chemically induced RCC, squalene displayed chemopreventive capabilities by substantial reversal of lipid peroxidation, mitochondrial redox regulation, maintaining ∆ψm, inflammation [Akt, nuclear factor κB (NF-κB)], angiogenesis (VEGFα), metastasis [matrix metalloproteinase 2 (MMP-2)], and survival (Bax/Bcl2, cytochrome-c, Casp3). Squalene restored glutathione, glutathione reductase, glutathione-s-transferase, catalase, and superoxide dismutase and stabilized alkaline phosphatase, alkaline transaminase, and aspartate transaminase. The correlation of thiobarbituric acid reactive substance with VEGF/NF-κB and negative association of GSH with Casp3 show that squalene employs reduction in ROS regulation. Cytokinesis-block micronuclei (CBMN) assay in VHLwt/mut cells revealed both direct and bystander effects of squalene with increased micronucleus (MN) frequency. Clastogenicity analysis of rat bone marrow cells demonstrated an anti-clastogenic effect of squalene, with increased polychromatic erythrocytes (PCEs), decreased MNPCE,s and MN normochromatic erythrocytes. Squalene could effectively target HIF signaling that orchestrate RCC evolution. The efficacy of squalene is similar in VHLwt and VHLmut RCC cells, and hence, squalene could serve as a promising drug candidate for an RCC cure beyond VHL status and VHL-HIF interaction dependency. Summary: Squalene derived from marine brown algae displays strong anti-cancer (RCC) activity, functionally targeting HIF-signaling pathway, and affects various cellular process. The significance of squalene effect for RCC is highlighted by its efficiency beyond VHL status, designating itself a promising drug candidate.
Similar content being viewed by others
Data availability
All data pertaining to this study is presented within this manuscript and in the supplementary figures.
Abbreviations
- ALP:
-
alkaline phosphatase
- ALT:
-
alkaline transaminase
- AST:
-
aspartate transaminase
- BLM:
-
bleomycin
- BSE:
-
bystander effect
- BUN:
-
blood urea nitrogen
- Casp3:
-
caspase-3
- CAT:
-
catalase
- CBMN:
-
cytokinesis-block micronuclei
- ccRCC:
-
clear cell RCC
- CDNB:
-
1,chloro-2,4,dinitrobenzene
- DAPI:
-
4′,6-diamidino-2-phenylindole
- DE:
-
direct effect
- DTNB:
-
dithionitrobenzene
- EA:
-
ethylacetate
- ELISA:
-
enzyme-linked immunosorbent assay
- GAPDH:
-
glyceraldehyde 3-phosphate dehydrogenase
- GR:
-
glutathione reductase
- GSH:
-
glutathione
- GST:
-
glutathione-s-transferase
- H&E:
-
hematoxylin and Eosin
- HIF:
-
hypoxia inducible factor
- HIF1α:
-
hypoxia inducible factor 1 α alpha
- HIF2 α:
-
hypoxia inducible factor 2 α
- ICI:
-
immune checkpoint inhibitor
- IHC:
-
immunohistochemistry
- KBrO3 :
-
potassium bromate
- KCl:
-
potassium chloride
- LPO:
-
lipid peroxidation
- MAPK:
-
mitogen-activated protein kinases
- MDA:
-
malondialdehyde
- MMP-2:
-
matrix metalloproteinase 2
- MN:
-
micronuclei
- MNNCE:
-
micronuclei normochromatic erythrocytes
- MNPCE:
-
micronuclei polychromatic erythrocytes
- MTT:
-
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
- NF-κB:
-
nuclear factor kappa B
- pAkt:
-
phospho-specific AKT at Ser473
- PCE:
-
polychromatic erythrocytes
- PMS:
-
post-mitochondrial supernatant
- qPCR:
-
quantitative polymerase chain reaction
- RCC:
-
renal cell carcinoma
- ROS:
-
reactive oxygen species
- SOD:
-
superoxide dismutase
- SQ:
-
squalene
- SRB:
-
sulforhodamine B
- TBA:
-
thiobarbituric acid
- TBARS:
-
thiobarbituric acid reactive substance
- TCA:
-
trichloroacetic acid
- TNFα:
-
tumor necrosis factor α
- VEGFα:
-
vascular endothelial growth factor α
- VHL:
-
von Hippel-Lindau
References
Albini A, Noonan DM, Ferrari N. Molecular pathways for cancer angioprevention. Clin Cancer Res. 2007;13:4320–5.
Amarowicz R. Squalene: a natural antioxidant? Eur J Lipid Sci Technol. 2009;111:411–2.
American-Cancer-Society. Cancer facts & figures 2020, vol. 1. Atlanta: American Cancer Society; 2020. p. 1–76.
Aravindan S, Delma CR, Thirugnanasambandan SS, Herman TS, Aravindan N. Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae. PLoS One. 2013;8:e61977.
Aravindan S, Ramraj SK, Somasundaram ST, Herman TS, Aravindan N. Polyphenols from marine brown algae target radiotherapy-coordinated EMT and stemness-maintenance in residual pancreatic cancer. Stem Cell Res Ther. 2015;6:182.
Athar M, Iqbal M. Ferric nitrilotriacetate promotes N-diethylnitrosamine-induced renal tumorigenesis in the rat: implications for the involvement of oxidative stress. Carcinogenesis. 1998;19:1133–9.
Barker SB. The direct colorimetric determination of urea in blood and urine. J Biol Chem. 1944;152:453–63.
Basso D, Panozzo MP, Plebani M, Meggiato T, Zaninotto M, Piccoli A, et al. Lipid peroxidation and renal tubular damage in chronic pancreatic diseases: is there any relationship? J Med. 1994;25:91–104.
Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW, et al. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell. 2009;4:226–35.
Brodaczewska KK, Szczylik C, Fiedorowicz M, Porta C, Czarnecka AM. Choosing the right cell line for renal cell cancer research. Mol Cancer. 2016;15:83.
Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75:74–84.
Catania JM, Chen G, Parrish AR. Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Ren Physiol. 2007;292:F905–11.
40 CFR 798.5395. In vivo, mammalian bone marrow cytogenetics tests: Micronucleus assay
Chakraborty AA. Coalescing lessons from oxygen sensing, tumor metabolism, and epigenetics to target VHL loss in kidney cancer. Semin Cancer Biol. 2020.
Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A. 1998;95:11715–20.
Costa MA, Mangione MR, Santonocito R, Passantino R, Giacomazza D, Librizzi F, et al. Biophysical characterization of asolectin-squalene liposomes. Colloids Surf B: Biointerfaces. 2018;170:479–87.
Dai ZJ, Gao J, Ma XB, Yan K, Liu XX, Kang HF, et al. Up-regulation of hypoxia inducible factor-1alpha by cobalt chloride correlates with proliferation and apoptosis in PC-2 cells. J Exp Clin Cancer Res. 2012;31:28.
Delker D, Hatch G, Allen J, Crissman B, George M, Geter D, et al. Molecular biomarkers of oxidative stress associated with bromate carcinogenicity. Toxicology. 2006;221:158–65.
Delma CR, Somasundaram ST, Srinivasan GP, Khursheed M, Bashyam MD, Aravindan N. Fucoidan from Turbinaria conoides: a multifaceted ‘deliverable’ to combat pancreatic cancer progression. Int J Biol Macromol. 2015;74:447–57.
Fan SR, Ho IC, Yeoh FL, Lin CJ, Lee TC. Squalene inhibits sodium arsenite-induced sister chromatid exchanges and micronuclei in Chinese hamster ovary-K1 cells. Mutat Res. 1996;368:165–9.
Feldenberg LR, Thevananther S, del Rio M, de Leon M, Devarajan P (1999) Partial ATP depletion induces Fas- and caspase-mediated apoptosis in MDCK cells. Am J Physiol 276:F837–F846.
Fu R, Ma X, Bian Z, Ma J. Digital separation of diaminobenzidine-stained tissues via an automatic color-filtering for immunohistochemical quantification. Biomed Opt Express. 2015;6:544–58.
Gago-Dominguez M, Castelao JE. Lipid peroxidation and renal cell carcinoma: further supportive evidence and new mechanistic insights. Free Radic Biol Med. 2006;40:721–33.
Gago-Dominguez M, Castelao JE, Yuan JM, Ross RK, Yu MC. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control. 2002;13:287–93.
Giri U, Iqbal M, Athar M. Potassium bromate (KBrO3) induces renal proliferative response and damage by elaborating oxidative stress. Cancer Lett. 1999;135:181–8.
Gorospe M, Egan JM, Zbar B, Lerman M, Geil L, Kuzmin I, et al. Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells. Mol Cell Biol. 1999;19:1289–300.
Gossage L, Eisen T, Maher ER. VHL, the story of a tumour suppressor gene. Nat Rev Cancer. 2015;15:55–64.
Haase VH. The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease. Kidney Int. 2006;69:1302–7.
Habig WH, Pabst MJ, Fleischner G, Gatmaitan Z, Arias IM, Jakoby WB. The identity of glutathione S-transferase B with ligandin, a major binding protein of liver. Proc Natl Acad Sci U S A. 1974;71:3879–82.
Hayashi M, Hashimoto S, Sakamoto Y, Hamada C, Sofuni T, Yoshimura I. Statistical analysis of data in mutagenicity assays: rodent micronucleus assay. Environ Health Perspect. 1994;102(Suppl 1):49–52.
Hayashi M, MacGregor JT, Gatehouse DG, Adler ID, Blakey DH, Dertinger SD, et al. In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring. Environ Mol Mutagen. 2000;35:234–52.
Heddle JA. A rapid in vivo test for chromosomal damage. Mutat Res. 1973;18:187–90.
Hong Y, Yan W, Chen S, Sun CR, Zhang JM. The role of Nrf2 signaling in the regulation of antioxidants and detoxifying enzymes after traumatic brain injury in rats and mice. Acta Pharmacol Sin. 2010;31:1421–30.
Jackson C. Matrix metalloproteinases and angiogenesis. Curr Opin Nephrol Hypertens. 2002;11:295–9.
Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 1974;11:151–69.
Jonasch E, Gao J, Rathmell WK. Renal cell carcinoma. BMJ. 2014;349:g4797.
Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984;21:130–2.
Kallio PJ, Pongratz I, Gradin K, McGuire J, Poellinger L. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci U S A. 1997;94:5667–72.
Kaminskyy VO, Zhivotovsky B. Free radicals in cross talk between autophagy and apoptosis. Antioxid Redox Signal. 2014;21:86–102.
Karthikeyan R, Manivasagam T, Anantharaman P, Balasubramanian T, Somasundaram ST. Chemopreventive effect of Padina boergesenii extracts on ferric nitrilotriacetate (Fe-NTA)-induced oxidative damage in Wistar rats. J Appl Phycol. 2011;23:257–63.
Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 2006;70:1469–80.
Kim SK, Karadeniz F. Biological importance and applications of squalene and squalane. Adv Food Nutr Res. 2012;65:223–33.
Kind PR, King EJ. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J Clin Pathol. 1954;7:322–6.
Kolisetty N, Delker DA, Muralidhara S, Bull RJ, Cotruvo JA, Fisher JW, et al. Changes in mRNA and protein expression in the renal cortex of male and female F344 rats treated with bromate. Arch Toxicol. 2013;87:1911–25.
Kondoh M, Ohga N, Akiyama K, Hida Y, Maishi N, Towfik AM, et al. Hypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironment. PLoS One. 2013;8:e80349.
Kurokawa Y, Aoki S, Matsushima Y, Takamura N, Imazawa T, Hayashi Y. Dose-response studies on the carcinogenicity of potassium bromate in F344 rats after long-term oral administration. J Natl Cancer Inst. 1986;77:977–82.
Leng S, Hao Y, Du D, Xie S, Hong L, Gu H, et al. Ursolic acid promotes cancer cell death by inducing Atg5-dependent autophagy. Int J Cancer. 2013;133:2781–90.
Li YX, Himaya SW, Kim SK. Triterpenoids of marine origin as anti-cancer agents. Molecules. 2013;18:7886–909.
Limoli CL, Kaplan MI, Corcoran J, Meyers M, Boothman DA, Morgan WF. Chromosomal instability and its relationship to other end points of genomic instability. Cancer Res. 1997;57:5557–63.
Lua J, Qayyum T, Edwards J, Roseweir AK. The prognostic role of the non-canonical nuclear factor-kappa B pathway in renal cell carcinoma patients. Urol Int. 2018;101:190–6.
Lusini L, Tripodi SA, Rossi R, Giannerini F, Giustarini D, del Vecchio MT, et al. Altered glutathione anti-oxidant metabolism during tumor progression in human renal-cell carcinoma. Int J Cancer. 2001;91:55–9.
Meteoglu I, Erdogdu IH, Meydan N, Erkus M, Barutca S. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues. J Exp Clin Cancer Res. 2008;27:53.
Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller DJ. Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney. Possible implications in analgesic nephropathy. Biochem Pharmacol. 1984;33:1801–7.
Motzer RJ, Hutson TE, Glen H, Michaelson MD, Molina A, Eisen T, et al. Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial. Lancet Oncol. 2015;16:1473–82.
Nakagawa M, Yamaguchi T, Fukawa H, Ogata J, Komiyama S, Akiyama S, et al. Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor. Jpn J Cancer Res. 1985;76:315–20.
Naveen Kumar DRS, Cijo George V, Suresh PK, Ashok Kumar R. Anticancer and anti-metastatic activities of Rheum emodi rhizome chloroform extracts. Asian J Pharmaceut Clin Res. 2012;3:189–94.
Newmark HL. Squalene, olive oil, and cancer risk. Review and hypothesis. Ann N Y Acad Sci. 1999;889:193–203.
Obaidi I, Higgins M, Bahar B, Davis JL, McMorrow T. Identification of the multifaceted Chemopreventive activity of Curcumin against the carcinogenic potential of the food additive, KBrO3. Curr Pharm Des. 2018;24:595–614.
Peters JH. The determination of creatinine and creatine in blood and urine with the photoelectric colorimeter. J Biol Chem. 1942;146:179–86.
Rajamani K, Balasubramanian T, Thirugnanasambandan SS. Bioassay-guided isolation of triterpene from brown alga Padina boergesenii possess anti-inflammatory and anti-angiogenic potential with kinetic inhibition of β-carotene linoleate system. LWT. 2018;93:549–55.
Rajamani K, Thirugnanasambandan SS. Polyphenols from brown alga, Padina boergesenii (Allendar & Kraft) decelerates renal cancer growth involving cell cycle arrest and induction of apoptosis in renal carcinoma cells. Environ Toxicol. 2018;33:1135–42.
Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL, et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol. 2005;25:5675–86.
Reddy LH, Couvreur P. Squalene: a natural triterpene for use in disease management and therapy. Adv Drug Deliv Rev. 2009;61:1412–26.
Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957;28:56–63.
Rosa R, Damiano V, Nappi L, Formisano L, Massari F, Scarpa A, et al. Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer. Br J Cancer. 2013;109:686–93.
Sai K, Hayashi M, Takagi A, Hasegawa R, Sofuni T, Kurokawa Y. Effects of antioxidants on induction of micronuclei in rat peripheral blood reticulocytes by potassium bromate. Mutat Res. 1992;269:113–8.
Sai K, Tyson CA, Thomas DW, Dabbs JE, Hasegawa R, Kurokawa Y. Oxidative DNA damage induced by potassium bromate in isolated rat renal proximal tubules and renal nuclei. Cancer Lett. 1994;87:1–7.
Sarada SKS, Sairam M, Dipti P, Anju B, Pauline T, Kain AK, Sharma SK, Bagawat S, Ilavazhagan G, Kumar D (2002). Role of selenium in reducing hypoxia-induced oxidative stress: an in vivo study. Biomed Pharmacother 56:173–8
Schietke RE, Hackenbeck T, Tran M, Gunther R, Klanke B, Warnecke CL, et al. Renal tubular HIF-2alpha expression requires VHL inactivation and causes fibrosis and cysts. PLoS One. 2012;7:e31034.
Schmid W. The micronucleus test. Mutat Res. 1975;31:9–15.
Shiao YH, Kamata SI, Li LM, Hooth MJ, DeAngelo AB, Anderson LM, et al. Mutations in the VHL gene from potassium bromate-induced rat clear cell renal tumors. Cancer Lett. 2002;187:207–14.
Shinojima T, Oya M, Takayanagi A, Mizuno R, Shimizu N, Murai M. Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha. Carcinogenesis. 2007;28:529–36.
Sinha AK. Colorimetric assay of catalase. Anal Biochem. 1972;47:389–94.
Tarade D, Ohh M. The HIF and other quandaries in VHL disease. Oncogene. 2018;37:139–47.
Thompson JM, Alvarez A, Singha MK, Pavesic MW, Nguyen QH, Nelson LJ, et al. Targeting the Mevalonate pathway suppresses VHL-deficient CC-RCC through an HIF-dependent mechanism. Mol Cancer Ther. 2018;17:1781–92.
von Ledebur M, Schmid W. The micronucleus test. Methodological aspects. Mutat Res. 1973;19:109–17.
Wang S-W, Pan S-L, Guh J-H, Chen H-L, Huang D-M, Chang Y-L, et al. YC-1 [3-(5′-Hydroxymethyl-2′-furyl)-1-benzyl Indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G0-G1 in human hepatocellular carcinoma cells. J Pharmacol Exp Ther. 2005;312:917–25.
Warleta F, Campos M, Allouche Y, Sanchez-Quesada C, Ruiz-Mora J, Beltran G, et al. Squalene protects against oxidative DNA damage in MCF10A human mammary epithelial cells but not in MCF7 and MDA-MB-231 human breast cancer cells. Food Chem Toxicol. 2010;48:1092–100.
Wolf DC, Crosby LM, George MH, Kilburn SR, Moore TM, Miller RT, et al. Time- and dose-dependent development of potassium bromate-induced tumors in male Fischer 344 rats. Toxicol Pathol. 1998;26:724–9.
Wright JR, Colby HD, Miles PR. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch Biochem Biophys. 1981;206:296–304.
Yamai H, Sawada N, Yoshida T, Seike J, Takizawa H, Kenzaki K, et al. Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo. Int J Cancer. 2009;125:952–60.
Yang YF, Chang YC, Jan YH, Yang CJ, Huang MS, Hsiao M. Squalene synthase promotes the invasion of lung cancer cells via the osteopontin/ERK pathway. Oncogenesis. 2020;9:78.
Acknowledgments
The authors thank Central Research Facility, Sri Ramachandra Institute of Higher Education and Research; Dr. Arulkumaran Shanmugam, Microbiology and Immunology, New York Medical College; and Dr. T. Radhiga and Dr. V.C. Renju, Department of Medical Biochemistry, Annamalai University for their support with laboratory access, reagents, and antibodies. The authors also acknowledge the OUHSC Staff Editor (Ms. Kathy Kyler) for the help in critically reviewing this manuscript.
Code availability
Not applicable.
Funding
Supported by the Department of Science and Technology (DST No: SR/SO/AS-04/2005) and the RMMCH clinical trial projects, Annamalai University, India, for the financial support (project assistant) to Dr. Karthikeyan Rajamani, and Department of Biotechnology, Ministry of Science and Technology (BT/PR11535/AAQ/03/431) to Dr. Somasundaram S Thirugnanasambandan.
Author information
Authors and Affiliations
Contributions
Designed the experiments: KR, ST, and NA. Shared their labs/reagents/kits: CN, SS, BT, and NA. Performed the experiment: KR and ST. Analyzed data: KR, ST, and NA. Manuscript draft: KR, NA, ST, CN, BT, and SS.
Corresponding authors
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Ethics approval
All animal experiments were carried out in accordance with the Guide for the Care and Use of Laboratory Animals (NIH Publication No.80-23 revised 1996) and approved (160/PO/ReBi/S/99/CPCSEA) by the Rajah Muthiah Institute of Medical Science, Institutional Animal Ethical Committee (IAEC)/Institutional Review Board (IRB), Annamalai University, Medical College, Annamalai Nagar.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Highlights
• Seaweed-derived squalene inhibits RCC cell survival and prompts DNA fragmentation and apoptosis.
• Squalene targets HIFs expression and HIF targets independent of the VHL status of the RCC cells.
• Squalene regulates mitochondrial ROS and lipid peroxidation and targets inflammatory signaling while prompting apoptotic machinery.
• Squalene exerted anti-genotoxic and anti-clastogenic effects in RCC cells and, together, could serve as a promising drug candidate for RCC treatment.
Rights and permissions
About this article
Cite this article
Rajamani, K., Thirugnanasambandan, S.S., Natesan, C. et al. Squalene deters drivers of RCC disease progression beyond VHL status. Cell Biol Toxicol 37, 611–631 (2021). https://doi.org/10.1007/s10565-020-09566-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10565-020-09566-w